Automated Filling Equipment Allows Increase in the Maximum Dose to Be Filled in the Cyclops(R)High Dose Dry Powder Inhalation Device While Maintaining Dispersibility

被引:11
作者
Sibum, Imco [1 ]
Hagedoorn, Paul [1 ]
Botterman, Carel O. [1 ]
Frijlink, Henderik W. [1 ]
Grasmeijer, Floris [1 ]
机构
[1] Univ Groningen, Fac Sci & Engn, Dept Pharmaceut Technol & Biopharm, NL-9700 AB Groningen, Netherlands
关键词
high dose pulmonary delivery; dry powder inhaler; automatic filling; vacuum drum filler; inhalation; tuberculosis; MATERIAL ATTRIBUTES; DELIVERY;
D O I
10.3390/pharmaceutics12070645
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In recent years there has been increasing interest in the pulmonary delivery of high dose dry powder drugs, such as antibiotics. Drugs in this class need to be dosed in doses far over 2.5 mg, and the use of excipients should therefore be minimized. To our knowledge, the effect of the automatic filling of high dose drug formulations on the maximum dose that can be filled in powder inhalers, and on the dispersion behavior of the powder, have not been described so far. In this study, we aimed to investigate these effects after filling with an Omnidose, a vacuum drum filler. Furthermore, the precision and accuracy of the filling process were investigated. Two formulations were used-an isoniazid formulation we reported previously and an amikacin formulation. Both formulations could be precisely and accurately dosed in a vacuum pressure range of 200 to 600 mbar. No change in dispersion was seen after automatic filling. Retention was decreased, with an optimum vacuum pressure range found from 400 to 600 mbar. The nominal dose for amikacin was 57 mg, which resulted in a fine particle dose of 47.26 +/- 1.72 mg. The nominal dose for isoniazid could be increased to 150 mg, resulting in a fine particle dose of 107.35 +/- 13.52 mg. These findings may contribute to the understanding of the upscaling of high dose dry powder inhalation products.
引用
收藏
页码:1 / 14
页数:14
相关论文
共 21 条
  • [1] The relationship between attractive interparticle forces and bulk behaviour in dry and uncharged fine powders
    Castellanos, A
    [J]. ADVANCES IN PHYSICS, 2005, 54 (04) : 263 - 376
  • [2] Powder Strength Distributions for Understanding De-agglomeration of Lactose Powders
    Das, Shyamal C.
    Behara, Srinivas Ravindra Babu
    Bulitta, Jurgen B.
    Morton, David A. V.
    Larson, Ian
    Stewart, Peter J.
    [J]. PHARMACEUTICAL RESEARCH, 2012, 29 (10) : 2926 - 2935
  • [3] Applications of capsule dosing techniques for use in dry powder inhalers
    Edwards, David
    [J]. THERAPEUTIC DELIVERY, 2010, 1 (01) : 195 - 201
  • [4] Low-dose capsule filling of inhalation products: Critical material attributes and process parameters
    Faulhammer, Eva
    Fink, Marlies
    Llusa, Marcos
    Lawrence, Simon M.
    Biserni, Stefano
    Calzolari, Vittorio
    Khinast, Johannes G.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2014, 473 (1-2) : 617 - 626
  • [5] Recent Advances in the Fundamental Understanding of Adhesive Mixtures for Inhalation
    Grasmeijer, Floris
    Grasmeijer, Niels
    Hagedoorn, Paul
    Frijlink, Henderik Willem
    de Boer, Anne Haaije
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (40) : 5900 - 5914
  • [6] ORDERED MIXING - NEW CONCEPT IN POWDER MIXING PRACTICE
    HERSEY, JA
    [J]. POWDER TECHNOLOGY, 1975, 11 (01) : 41 - 44
  • [7] The Cyclops for pulmonary delivery of aminoglycosides; a new member of the Twincer™ family
    Hoppentocht, M.
    Akkerman, O. W.
    Hagedoorn, P.
    Frijlink, H. W.
    de Boer, A. H.
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2015, 90 : 8 - 15
  • [8] Technological and practical challenges of dry powder inhalers and formulations
    Hoppentocht, M.
    Hagedoorn, P.
    Frijlink, H. W.
    de Boer, A. H.
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2014, 75 : 18 - 31
  • [9] The filling of powders into two-piece hard capsules
    Jones, BE
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 227 (1-2) : 5 - 26
  • [10] Pulmonary drug delivery. Part I: Physiological factors affecting therapeutic effectiveness of aerosolized medications
    Labiris, NR
    Dolovich, MB
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 56 (06) : 588 - 599